Work

A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia

Year: 2021

Type: article

Study design: Case Report

Abstract: We report on a novel, successful, non‐cytotoxic therapy to treat multiply‐refractory T‐LGL in an elderly patient.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.4533

Authors: Misam Zawit, Carmelo Gurnari, Simona Pagliuca, Hassan Awada, Jaroslaw P. Maciejewski, Yogen Saunthararajah

Institutions: Cleveland Clinic, University of Rome Tor Vergata, Université Paris Cité

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,210

Funders: American-Italian Cancer Foundation, Edward P. Evans Foundation, Henry and Marilyn Taub Foundation, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1970280874, Investigations of Consequences of U2AF1 Mutations in MDS, G3214780145, G4637436490, Therapeutic Implications of Molecular Defects in Bone Marrow Failure, G5116727711, Novel Spliceosomal Defects in Myelodysplastic Syndromes, RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target, G6142190875, Targeting Enzymatic Regulation of Fetal Hemoglobin Repression, G6433241947, G7378577264, Imaging Liver Cancer Proliferation, Case Comprehensive Cancer Center Support Grant

OpenAlex ID: W3161503403

FWCI: 1.146

Cites: 15

Cited by: 12

Related to: 10